Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 258, Issue 1-2, Pages 27-31Publisher
ELSEVIER
DOI: 10.1016/j.jneuroim.2013.02.010
Keywords
Interferon beta; Peripheral blood mononuclear cell; B cell; B7.2; Costimulation; Multiple sclerosis
Categories
Funding
- EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany
- EMD Serono, Inc.
- Pfizer Inc.
- Pfizer Inc, New York, NY, USA
Ask authors/readers for more resources
The effect of pharmacologically relevant doses of interferon (IFN) beta-1a on B-cell expression of B7.1 and B7.2 was investigated. Culture of peripheral blood mononuclear cells with IFN beta-1a 100 IU/mL decreased B-cell expression of B7.1 and increased B7.2 expression. Interleukin-10 in B cells was significantly enhanced by IFN beta-1a. Anti-CD3 and anti-CD28 monoclonal antibody-mediated T-cell proliferations were partially suppressed in the presence of B cells pretreated with IFN beta-1a. These data suggest that IFN beta-1a and B cells can interact to play a beneficial role in the treatment of multiple sclerosis. (C) 2013 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available